Drug recall · September 4, 2013
Magnesium Sulfate Injection recall
Why: Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Magnesium Sulfate Injection, USP, 50% (25 grams/50 mL), For IM or IV Use, 50 mL, Single Dose Vial, Rx only, Preservative Free, APP Pharmaceuticals, LLC, Schaumburg, IL, 60173, NDC 63323-064-50
- Lots / codes
Lot #: 6103882, Exp 10/14
- Quantity
- 15,625 vials
- Company
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Distribution
- Nationwide
- Initiated
- May 25, 2013 · Voluntary: Firm initiated
- Classified
- August 23, 2013
- Reported
- September 4, 2013
- Ended
- March 10, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Magnesium sulfate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.